CRYBG2 and ovarian cancer: By exploring AIM1L in the National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov/), it was found that it was highly expressed in normal human tissues such as the esophagus and skin.[5] A mass spectrometry analysis showed that AIM1L mRNA was highly expressed in some cancer cell lines, including breast cancer, colon cancer, ovarian cancer, and in noncancerous tissues only in the placenta.